Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Ross T. Burn

The Power List 2021 – Small Molecules


Chief Executive Officer at CatSci Ltd

After completing his PhD in 2007, Ross joined AstraZeneca as a Senior Analytical Chemist in process R&D. Burn helped launch CatSci Ltd in 2011 and became its Chief Executive Officer in 2015. “Even though new therapeutic modalities are on the rise, there are still limitations to their efficacy, scalability, patient tolerability, and wider adoption by healthcare providers. Small molecule therapeutics will always play a key role in combating diseases due to their relative affordability, greener profile, and well-understood development processes. Additionally, with advances in chemistry, the industry can uncover new molecular entities with unprecedented target activity that can be manufactured at a speed and cost not feasible 10 years ago.”


Part of the Power List 2021

Find out more

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products

Go to The Power List 2021

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register